Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]
Hoggatt J, Tate TA, Pelus LM. Int J Nanomed. 2015;10:2647–2652.In this article, Lipegfilgrastim was referred to as a "long-acting biosimilar filgrastim". The term "biosimilar" was used too broadly in this case, as Lipegfilgrastim was not approved under t...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c6fde9992f154241970ca9e958d79a30 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|